Abstracts tagged "multicenter study and uveitis"

Abstract Number: 1773 • 2018 ACR/ARHP Annual Meeting
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis Due to Behçet’s Disease. National Multicenter Study of 177 Cases
Belén Atienza-Mateo¹, José Luis Martín-Varillas¹, Vanesa Calvo-Río², Rosalía Demetrio-Pablo³, Emma Beltrán⁴, Marina Mesquida⁵, Alfredo Adan⁵, Juan Sánchez Bursón Sr.⁶, M. Victoria Hernández⁷, Marisa Hernández⁸, Elia Valls-Pascual⁹, L. Martinez-Costa⁹, Agusti Sellas-Fernandez¹⁰, Miguel Cordero-Coma¹¹, Manuel Díaz-Llopis¹², Roberto Gallego¹², Jose L. García Serrano¹³, Norberto Ortego Centeno¹⁴, Angel Garcia-Aparicio¹⁵, Olga Maiz-Alonso¹⁶, Ana Blanco¹⁷, Cruz Fernandez-Espartero¹⁸, Vega Jovaní¹⁹, Diana Peiteado²⁰, Elena Aurrecoechea²¹, Amalia Sanchez-Andrade²², Enrique Minguez²³, Carmen Carrasco-Cubero²⁴, Alejandro Olivé-Marqués²⁵, Esteban Rubio-Romero²⁶, Francisco J. Toyos Sáenz de Miera²⁷, David Diaz-Valle²⁸, Joan Miquel Nolla²⁹, Marcelino Revenga Martínez³⁰, Santos Castañeda³¹, Jose M Herreras³², Alejandro Fonollosa³³, Ignacio Torre-Salaberri³⁴, Esperanza Pato Cour³⁵, Juan Cruz³⁶, Carlos Férnandez Cid³⁷, Miriam García-Arias³⁸, Miguel Angel Caracuel-Ruiz³⁹, Carlos Alberto Montilla-Morales⁴⁰, Antonio Atanes⁴¹, Félix Francisco⁴², Santos Insua⁴³, Senen González-Suárez⁴⁴, Fernando Gamero⁴⁵, Luis Francisco Linares⁴⁶, Fredeswinda I. Romero-Bueno⁴⁷, Raquel Almodóvar González⁴⁸, Julio Vázquez⁴⁹, A. Javier García-González⁵⁰, Oscar Ruiz Moreno⁵¹, Fernando Jiménez-Zorzo⁵¹, Javier Manero⁵¹, Santiago Muñoz Fernandez⁵², Fred Antón Pages⁵³, Myriam Gandía⁵⁴, Francisco Javier López Longo⁵⁵, Enrique Raya Álvarez⁵⁶, Paz Rodríguez-Cundín⁵⁷, Diana Prieto Peña², Monica Calderón Goercke², Enar Pons¹, José Luis Hernández³, Miguel Angel González-Gay¹ and Ricardo Blanco¹, ¹Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ²Rheumatology, Rheumatology. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ³Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, ⁴Rheumatology, Hospital del Mar. Barcelona. Spain, Barcelona, Spain, ⁵Hospital Clinic. Barcelona. Spain, Barcelona, Spain, ⁶Rheumatology, Hospital de Valme. Sevilla. Spain, Sevilla, Spain, ⁷Rheumatology, Hospital Clinic. Barcelona. Spain, Barcelona, Spain, ⁸Ophthalmology, Hospital General Universitario de Valencia. Spain, Valencia, Spain, ⁹Hospital Universitario Doctor Peset. Valencia. Spain, Valencia, Spain, ¹⁰Vall d'Hebron Hospital Research Institute, Barcelona, Spain, ¹¹Ophthalmology, Hospital de León. Spain, León, Spain, ¹²Hospital Universitario La Fe. Valencia. Spain, Valencia, Spain, ¹³Ophthalmology, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, ¹⁴Medicine Department, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, ¹⁵Rheumatology, Hospital de Toledo. Toledo. Spain, Toledo, Spain, ¹⁶Hospital Universitario Donostia. San Sebastian. Spain, Donostia, Spain, ¹⁷Ophtamology, Hospital Universitario Donostia. San Sebastian. Spain, San Sebastian, Spain, ¹⁸Rheumatology, Hospital de Móstoles. Madrid. Spain, Madrid, Spain, ¹⁹Rheumatology, Hospital General Universitario de Alicante. Spain, Alicante, Spain, ²⁰Rheumatology, Rheumatology, La Paz University Hospital, Madrid, Spain, ²¹Rheumatology, Hospital de Sierrallana, Torrelavega. Cantabria. Spain, Torrelavega, Spain, ²²Rheumatology, Hospital Lucus Augusti. Lugo. Spain, Lugo, Spain, ²³Ophthalmology, Hospital Clínico de Zaragoza. Spain, Zaragoza, Spain, ²⁴Hospital de Mérida. Spain, Mérida, Spain, ²⁵Rheumatology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, ²⁶Hospital Universitario Virgen del Rocío. Sevilla. Spain, Sevilla, Spain, ²⁷Hospital Virgen de La Macarena. Sevilla. Spain, Sevilla, Spain, ²⁸Hospital Clínico San Carlos. Madrid. Spain, Madrid, Spain, ²⁹Rheumatology, Hospital Universitario de Bellvitge, Barcelona, Spain, ³⁰Hospital Universitario Ramón y Cajal. Madrid. Spain, Madrid, Spain, ³¹Rheumatology, Rheumatology Department, Hospital Universitario la Princesa, IIS-Princesa, Madrid, Spain, ³²Ophthalmology, Hospital Universitario, IOBA. Valladolid. Spain, Valladolid, Spain, ³³Ophthalmology, Hospital de Cruces. Bilbao. Spain, Bilbao, Spain, ³⁴Rheumatology, Hospital Universitario de Basurto. Bilbao. Spain, Bilbao, Spain, ³⁵Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, ³⁶Rheumatology, Hospital de Pontevedra. Pontevedra. Spain, Pontevedra, Spain, ³⁷Ophthalmology, Hospital de Pontevedra. Pontevedra. Spain, Pontevedra, Spain, ³⁸Hospital Universitario de la Princesa. Madrid. Spain, Madrid, Spain, ³⁹Rheumatology service, Hospital Universitario Reina Sofía. Córdoba. Spain, Córdoba, Spain, ⁴⁰Hospital Clínico Universitario de Salamanca. Spain, Salamanca, Spain, ⁴¹Complejo Hospitalario Universitario A Coruña. Spain, A Coruna, Spain, ⁴²Rheumatology, Hospital Doctor Negrín. Las Palmas de Gran Canaria. Spain, Las Palmas de Gran Canaria, Spain, ⁴³Rheumatology, Hospital Universitario Santiago de Compostela. La Coruña. Spain, La Coruña, Spain, ⁴⁴Rheumatology, Hospital de Cabueñes. Gijón. Spain, Gijón, Spain, ⁴⁵Rheumatology, Hospital San Pedro Alcántara. Cáceres. Spain, Cáceres, Spain, ⁴⁶Rheumatology, Hospital Virgen de la Arrixaca. Murcia. Spain, Murcia, Spain, ⁴⁷Section for Autoimmune Diseases, Rheumatology, Fundación Jiménez Díaz University Hospital & Health Research Institute, Madrid, Spain, ⁴⁸Rheumatology, Hospital Universitario Fundación Alcorcón. Madrid. Spain, Madrid, Spain, ⁴⁹Rheumatology, Hospital de Ferrol. La Coruña. Spain, La Coruña, Spain, ⁵⁰Rheumatology, Instituto de Investigación Hospital 12 de octubre. Madrid. Spain, Madrid, Spain, ⁵¹Ophthalmology and Rheumatology, Hospital Miguel Servet. Zaragoza. Spain, Zaragoza, Spain, ⁵²Hospital Universitario Infanta Sofía. Madrid. Spain, San Sebastián de los Reyes (Madrid), Spain, ⁵³Rheumatology, Hospital Universitario Virgen del Rocío. Sevilla. Spain, Sevilla, Spain, ⁵⁴Rheumatology, Hospital Puerta del Mar. Cádiz. Spain, Cádiz, Spain, ⁵⁵Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain, ⁵⁶Rheumatology, Hospital Universitario San Cecilio. Granada. Spain, Granada, Spain, ⁵⁷Preventive Medicine, Preventive Medicine. Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain., Santander, Spain
Background/Purpose: Uveitis is one of the major causes of disability of Behçet's disease (BD). According to the “Expert panel recommendations” (Ophthalmology. 2014; 121:785-96), anti-TNF therapy…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].